Bildkälla: Stockfoto

Medivir: Tango Project Cancelled - Redeye

Redeye comments on Tango Therapeutics' discontinuation of the USP1 programme (TNG348), which does not have an impact on our base case.

Redeye comments on Tango Therapeutics' discontinuation of the USP1 programme (TNG348), which does not have an impact on our base case.
Börsvärldens nyhetsbrev
ANNONSER